Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021)
Vicarious Surgical (RBOT) posted quarterly Non-Current Deffered Revenue of $1.6 million for Q4 2021, up 2712.07% year-over-year from $58000.0 in Q4 2020, and up 11.18% quarter-over-quarter from $1.5 million in Q3 2021.
Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has reported Non-Current Deffered Revenue for 2 consecutive years, with $1.6 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Non-Current Deffered Revenue rose 2712.07% year-over-year to $1.6 million; the TTM figure through Dec 2021 stood at $1.6 million (up 2712.07% YoY), while the FY2021 annual figure was $1.6 million, up 2712.07% from the prior year.
- Non-Current Deffered Revenue grew to $1.6 million in Q4 2021 per RBOT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $12.1 million in Q3 2020 and bottomed at $58000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 12.08 Mn |
| Mar 31, 2021 | 12.08 Mn |
| Dec 31, 2020 | 58,000.00 |
| Sep 30, 2020 | 12.08 Mn |